Volmex Finance has introduced perpetual futures contracts based on its Bitcoin Volmex Implied Volatility Index (BVIV) on the decentralized exchange Hyperliquid. This product allows traders to speculate on Bitcoin's expected volatility, similar to the VIX for stocks, but accessible with up to 5x leverage and without traditional brokerage barriers. The BVIV index measures Bitcoin's 30-day implied volatility using options data from major platforms, and the futures contract offers a linear payout in USDC with isolated margin to limit risk. This launch expands Hyperliquid's offerings beyond price speculation, providing new hedging and trading opportunities, though volatility trading carries risks like sharp index gaps that can lead to liquidations.
Volmex Finance's new Bitcoin implied volatility futures launch is context for crypto market activity. For readers following major cryptocurrencies on Pluang, here is the market snapshot as of Sep 30, 2026 02:42 WIB: 27 of 50 major cryptocurrencies rose and 22 fell. EOS rose 8.13% to Rp12.649 with a typical hold time of 87 days, CRV rose 7.57% to Rp6.975 with 96% buy orders, while ONE fell 7.53% to Rp44 with 57% sell orders.
GameStop's CEO Ryan Cohen and other executives have made significant insider purchases of millions of shares, showing strong confidence in the company's future despite recent stock price volatility. These buys were active decisions, not pre-scheduled...
Concentrix Corporation reported mixed Q3 2026 results with earnings per share of $2.92, beating analyst expectations of $2.71. However, its revenue of $2.45 billion slightly missed the forecast of $2.48 billion. The company achieved a record free cas...
Accenture is set to report Q3 2026 earnings on October 1, with analysts forecasting $18.03 billion in revenue, a 5.6% increase year-over-year, and earnings per share around $3.18. The growth is fueled by strong demand for AI services, with 100 new ad...
Iovance Biotherapeutics shares jumped 31.48% after raising its 2026 revenue forecast, driven by strong demand for its cancer immunotherapy Amtagvi. SoundThinking's stock rose 50.09% following an acquisition agreement with Transom Capital Group, offer...
Shares of uniQure dropped 37.33% following mixed clinical data for its Huntington's disease gene therapy. Fair Isaac fell 26.52% after U.S. regulators expanded the use of competitor VantageScore in mortgage credit scoring, threatening its market posi...
